EGFR-Directed Therapy in Lung Cancer

This Element describes the structural biology and pathophysiology of EGFR- mutant NSCLC and describes past, current, and future treatment options in different settings. It discusses the biology and recently approved treatment for EGFR-exon 20 insertion mutation and the treatment for the uncommon mutations.